Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05266105
Title A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Olema Pharmaceuticals, Inc.
Indications

breast cancer

Therapies

OP-1250 + Palbociclib

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Site 6104 Not yet recruiting Westmead New South Wales 2145 Australia Details
Site 6102 Recruiting South Brisbane Queensland 4101 Australia Details
Site 6101 Recruiting Clayton Victoria 3168 Australia Details
Site 6103 Recruiting Geelong Victoria 3220 Australia Details
Site 6105 Recruiting Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field